Brovana (arformoterol tartrate)
Brovana (arformoterol tartrate)
is an inhalation solution that contains a long-acting beta2-adrenergic
agonist (LABA). Brovana is administered twice daily using a standard jet
nebulizer, and is indicated for use as a long-term maintenance
treatment for adults with COPD. Brovana is not a rescue therapy, meaning
it is not designed to treat sudden, severe COPD symptoms. However,
Brovana can be used in addition to a rescue treatment if needed to treat
acute bronchospasms when necessary. Individuals with asthma or liver,
cardiovascular, or convulsive disorders should not take Brovana.
Overdose of Brovana or use with other LABAs may be fatal.wisepoqder Arformoterol tartrate powder
What are the ingredients in Brovana?
The active ingredient in Brovana is arformoterol tartrate.
How does Brovana work?
Arformoterol
tartrate is a LABA. This means that it activates beta2-adrenergic
receptors in the body. Activation of these receptors sets off a chain of
events on a molecular level that leads to smooth muscle relaxation,
including relaxation of muscles in the airways. This smooth muscle
relaxation can open the airways and reduce bronchospasms. Additionally,
when these muscles are relaxed, common COPD symptoms like chest
tightness, shortness of breath, and wheezing may be improved. Brovana is
considered a maintenance therapy for COPD, meaning that it is used for
long-term management of the condition, and not for sudden, severe
symptoms or exacerbations. Rescue therapies, including medications
classified as short-acting beta2-adrenergic agonists (SABAs), are used
for immediate symptom relief, and can often be used alongside LABA
medications when necessary. If you think you may benefit from adding a
rescue medication to your maintenance therapy regimen, talk with your
doctor or healthcare provider.
Individuals with asthma should not
take Brovana. LABA medications, like Brovana, may increase the risk of
asthma-related death. Brovana is not to be used as a rescue therapy or
for immediate symptom relief. Individuals with liver impairment or a
history of liver issues should use Brovana cautiously. Individuals with
cardiovascular disorders, thyroid disorders, convulsive disorders, or
who are sensitive to sympathomimetic drugs (stimulating medications that
mimic the effects of the fight-or-flight response of the nervous
system) should not take Brovana. If your symptoms or breathing
difficulties worsen after taking Brovana, or if you develop increased
blood pressure or irregular heartbeat, stop use immediately and seek
medical attention.
